GlassScriptPhysician profile
Boris Goldman
NPI 1104821560
$1,576.82
in general payments reported to CMS, 2019-2025
10 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2021: $15.60 · 2022: $211 · 2023: $455 · 2024: $351 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,125.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $644.05 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Merz North America, INC. | $282.12 | 2019-2023 | |
| Galderma Laboratories, L.P. | $194.78 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $150.14 | 2024-2025 | Entyvio |
| Janssen Biotech, INC. | $110.50 | 2024-2025 | Tremfya, Stelara, Simponi Aria |
| Musculoskeletal Transplant Foundation INC. | $61.93 | 2024 | |
| Abbvie INC. | $52.01 | 2024 | |
| Allergan, INC. | $31.76 | 2019-2021 | |
| Genzyme Corporation | $27.63 | 2024 | |
| Smith+Nephew, INC. | $21.90 | 2023 | Pico |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boris Goldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.